PPMD Applauds FDA for Approval of DUVYZAT™ (Givinostat) for Duchenne Patients Ages Six Years and Older

Posted on by

WASHINGTON, March 21, 2024 /PRNewswire/ — Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), welcomed today’s decision by the Food and Drug Administration (FDA) to approve DUVYZAT™(givinostat) a histone…